Neptune Tech. & Bio. Stock Price (NASDAQ:NEPT)

Add to My Stocks
$2.81 $0.11 (3.77%) NEPT stock closing price Jul 20, 2018 (Closing)
Prev Close* : $2.92
Market Cap:
$222.59M
Day Low: $2.79
52 Week Low: $0.70
Open: $2.93
Volume: -
Day High: $2.94
52 Week High: $4.46
Dividend:
0.00

Latest Stock Market News

Latest Articles

Neptune Tech. & Bio. News - From Partners

NEPT Stockcharts

View NEPT PE ratio, PS ratio stocks charts and compare with peers.
NEPT Chart
Note: Compare Neptune Tech. & Bio. stock price history with the index and industry peers.

Neptune Tech. & Bio. Valuation

PE ratio
(price earnings ratio)
-999.0000
PS ratio (
price to sales ratio
)
-999.0000
PB ratio (
price to book ratio
)
-999.0000

Neptune Tech. & Bio. Returns

ROE
(return on equity)
-

Neptune Tech. & Bio. Financial Ratios

Asset Turnover
-
Receivables Turnover
-
Debt to Equity
0.05
Dividend Yield
-999.0000

NEPT Industry Peers

Company Price Change (%)
Durect (DRRX)1.510 (0%)
Avadel Pharma (AVDL)6.820.13 (1.87%)
Jounce Theraptc (JNCE)7.570.21 (2.7%)
Natural Alternatives International (NAII)10.260.11 (1.08%)
Integrated Biopharma (INBP)0.150 (0%)
Amarin (AMRN)2.80.03 (1.08%)
Abbott (ABT)63.320.46 (0.72%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
PTC Therapeutics (PTCT)39.983.43 (9.38%)
Adamis Pharma (ADMP)3.80.15 (4.11%)
Rigel Pharma (RIGL)3.10.12 (4.03%)
La Jolla Pharma (LJPC)32.271.21 (3.9%)
CASI Pharma (CASI)7.350.27 (3.81%)
CTI BioPharma (CTIC)2.350.08 (3.52%)
ArQule (ARQL)5.380.17 (3.26%)
Top gainers from Medical-Drugs industry
* As of Jul 21, 2018
CompanyPriceChange (%)
Neptune Tech. & Bio. (NEPT)2.810.11 (3.77%)
Redhill Biopharma (RDHL)9.960.39 (3.77%)
Achaogen (AKAO)7.140.27 (3.64%)
Infinity Pharma (INFI)1.910.07 (3.54%)
Lannett Co (LCI)12.350.45 (3.52%)
Galectin Therapeutics (GALT)5.620.2 (3.44%)
Tesaro Inc (TSRO)39.240.99 (2.46%)
Top losers from Medical-Drugs industry
* As of Jul 21, 2018

Neptune Technologies & Bioressources-Ord Stock News - Partner Headlines

Neptune Tech. & Bio. Financial Statements

income statement20162015201420132012
Net Sales or Revenues17.36M13.42M18.65M25.91M19.3M
Net Income-5.73M-26.56M-21.28M-19.99M-4.63M
Total Operating Expense14.84M28.11M39.7M25.82M15.94M
View Neptune Tech. & Bio. income statement
balance sheet20162015201420132012
Total Assets81.35M88.22M97.82M67.61M45.15M
Total Liabilities30.01M23.33M35.57M10.77M12.22M
Shareholders Equity51.34M64.89M62.25M56.84M32.93M
View Neptune Tech. & Bio. balance sheet
cash flow statement20162015201420132012
Net Increase (Decrease) in Assets Liabilities-1.58M9.59M-10.34M-0.93M-4.91M
Net Cash from (used by) Operating Activities-8.74M-20.26M-17.43M-1.76M-4.91M
Increase (Decrease) in Prop Plant And Equipment-0.92M-15.96M-15.79M-19.07M-0.91M
View Neptune Tech. & Bio. cash flow statement

Neptune Tech. & Bio. Stock Message Board

Neptune Tech. & Bio. stock lost 3.77%, and the last close price as of Jul 20, 2018 is $2.81 for NEPT stock. The total market value as denoted by $222.59M for Neptune Tech. & Bio., is the market value of the company's outstanding shares. Investors can use valuation multiples like the P/E ratio, price to sales ratio etc. for performing Neptune Tech. & Bio. stock analysis.

For recognizing and analyzing the real performance of Neptune Tech. & Bio. stock, it is a standard practise to adjust historical stock prices to remove gaps caused by stock splits, dividends and distributions. The volume number in Neptune Tech. & Bio. stock quote data shows the number of shares traded. For Ex: 454,982 Neptune Tech. & Bio. shares were traded as of last trading day, as seen from Neptune Tech. & Bio. stock chart. A dividend is a cash payment made from a company's earnings and is distributed among shareholders. Neptune Tech. & Bio. does not pay dividends. One can observe stock price trends and check for volatility by checking Neptune Tech. & Bio. stock price history.